癌细胞上的促红细胞生成素受体：一个仍未解决的问题。 - Suppr

Suppr

超能文献

Erythropoietin receptors on cancer cells: a still open question.

作者信息

Della Ragione Fulvio, Cucciolla Valeria, Borriello Adriana, Oliva Adriana, Perrotta Silverio

出版信息

J Clin Oncol. 2007 May 1;25(13):1812-3; author reply 1815. doi: 10.1200/JCO.2006.09.7212.

DOI:10.1200/JCO.2006.09.7212

PMID:17470877

Abstract

摘要

相似文献

Erythropoietin receptors on cancer cells: a still open question.

J Clin Oncol. 2007 May 1;25(13):1812-3; author reply 1815. doi: 10.1200/JCO.2006.09.7212.

An erythropoietin autocrine/paracrine axis modulates the growth and survival of human prostate cancer cells.

Mol Cancer Res. 2009 Jul;7(7):1150-7. doi: 10.1158/1541-7786.MCR-08-0243. Epub 2009 Jun 30.

Do cancer cells express functional erythropoietin receptors?

N Engl J Med. 2007 Jun 14;356(24):2447. doi: 10.1056/NEJMp078112.

Understanding the presence and function of erythropoietin receptors on cancer cells.

J Clin Oncol. 2006 Oct 10;24(29):4675-6. doi: 10.1200/JCO.2006.08.1190.

Erythropoietin receptors on tumor cells: what do they mean?

Oncologist. 2008;13 Suppl 3:16-20. doi: 10.1634/theoncologist.13-S3-16.

Problems in identifying functional erythropoietin receptors in cancer tissue.

J Clin Oncol. 2007 Apr 20;25(12):1627-8; author reply 1628. doi: 10.1200/JCO.2007.10.9728.

Erythropoietin and its lost receptor.

Nephrol Dial Transplant. 2007 May;22(5):1484-5. doi: 10.1093/ndt/gfl769. Epub 2007 Jan 31.

Erythropoietin and erythropoietin receptor in colorectal cancer.

Int J Surg Pathol. 2008 Jul;16(3):269-76. doi: 10.1177/1066896908315796. Epub 2008 May 15.

Examining the involvement of erythropoiesis-stimulating agents in tumor proliferation (erythropoietin receptors, receptor binding, signal transduction), angiogenesis, and venous thromboembolic events.

Oncologist. 2009;14 Suppl 1:34-42. doi: 10.1634/theoncologist.2009-S1-34.

The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):152-9. doi: 10.1016/j.ijrobp.2007.09.027. Epub 2007 Oct 29.

引用本文的文献

The endogenous erythropoietin in correlation with other erythrocytic parameters in patients with head and neck squamous cell carcinoma treated with platinum-based induction chemotherapy.

Contemp Oncol (Pozn). 2019;23(3):178-182. doi: 10.5114/wo.2019.89247. Epub 2019 Oct 31.

Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells.

Cancer Biol Ther. 2014 Jan;15(1):89-98. doi: 10.4161/cbt.26717. Epub 2013 Oct 22.

Epo receptors are not detectable in primary human tumor tissue samples.

PLoS One. 2013 Jul 4;8(7):e68083. doi: 10.1371/journal.pone.0068083. Print 2013.

The effect of erythropoietin on normal and neoplastic cells.

Biologics. 2012;6:163-89. doi: 10.2147/BTT.S32281. Epub 2012 Jun 27.

EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.

PLoS One. 2010 Aug 5;5(8):e12015. doi: 10.1371/journal.pone.0012015.

Recombinant human epoetin beta in the treatment of chemotherapy-related anemia.

Ther Clin Risk Manag. 2009 Feb;5(1):261-70. doi: 10.2147/tcrm.s3320. Epub 2009 Mar 26.

Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells.

Br J Cancer. 2008 Mar 25;98(6):1059-67. doi: 10.1038/sj.bjc.6604220. Epub 2008 Mar 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Erythropoietin receptors on cancer cells: a still open question.

作者信息

Della Ragione Fulvio, Cucciolla Valeria, Borriello Adriana, Oliva Adriana, Perrotta Silverio

出版信息

J Clin Oncol. 2007 May 1;25(13):1812-3; author reply 1815. doi: 10.1200/JCO.2006.09.7212.

DOI:10.1200/JCO.2006.09.7212

PMID:17470877

Abstract

摘要

相似文献

Erythropoietin receptors on cancer cells: a still open question.

J Clin Oncol. 2007 May 1;25(13):1812-3; author reply 1815. doi: 10.1200/JCO.2006.09.7212.

An erythropoietin autocrine/paracrine axis modulates the growth and survival of human prostate cancer cells.

Mol Cancer Res. 2009 Jul;7(7):1150-7. doi: 10.1158/1541-7786.MCR-08-0243. Epub 2009 Jun 30.

Do cancer cells express functional erythropoietin receptors?

N Engl J Med. 2007 Jun 14;356(24):2447. doi: 10.1056/NEJMp078112.

Understanding the presence and function of erythropoietin receptors on cancer cells.

J Clin Oncol. 2006 Oct 10;24(29):4675-6. doi: 10.1200/JCO.2006.08.1190.

Erythropoietin receptors on tumor cells: what do they mean?

Oncologist. 2008;13 Suppl 3:16-20. doi: 10.1634/theoncologist.13-S3-16.

Problems in identifying functional erythropoietin receptors in cancer tissue.

J Clin Oncol. 2007 Apr 20;25(12):1627-8; author reply 1628. doi: 10.1200/JCO.2007.10.9728.

Erythropoietin and its lost receptor.

Nephrol Dial Transplant. 2007 May;22(5):1484-5. doi: 10.1093/ndt/gfl769. Epub 2007 Jan 31.

Erythropoietin and erythropoietin receptor in colorectal cancer.

Int J Surg Pathol. 2008 Jul;16(3):269-76. doi: 10.1177/1066896908315796. Epub 2008 May 15.

Oncologist. 2009;14 Suppl 1:34-42. doi: 10.1634/theoncologist.2009-S1-34.

The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):152-9. doi: 10.1016/j.ijrobp.2007.09.027. Epub 2007 Oct 29.

引用本文的文献

The endogenous erythropoietin in correlation with other erythrocytic parameters in patients with head and neck squamous cell carcinoma treated with platinum-based induction chemotherapy.

Contemp Oncol (Pozn). 2019;23(3):178-182. doi: 10.5114/wo.2019.89247. Epub 2019 Oct 31.

Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells.

Cancer Biol Ther. 2014 Jan;15(1):89-98. doi: 10.4161/cbt.26717. Epub 2013 Oct 22.

Epo receptors are not detectable in primary human tumor tissue samples.

PLoS One. 2013 Jul 4;8(7):e68083. doi: 10.1371/journal.pone.0068083. Print 2013.

The effect of erythropoietin on normal and neoplastic cells.

Biologics. 2012;6:163-89. doi: 10.2147/BTT.S32281. Epub 2012 Jun 27.

EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.

PLoS One. 2010 Aug 5;5(8):e12015. doi: 10.1371/journal.pone.0012015.

Recombinant human epoetin beta in the treatment of chemotherapy-related anemia.

Ther Clin Risk Manag. 2009 Feb;5(1):261-70. doi: 10.2147/tcrm.s3320. Epub 2009 Mar 26.

Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells.

Br J Cancer. 2008 Mar 25;98(6):1059-67. doi: 10.1038/sj.bjc.6604220. Epub 2008 Mar 18.